A Long-term Study of the Medicine Called Abrocitinib in Children Aged 2 Years and Older With Moderate to Severe Eczema

Clinical trial NCT06807281 · RECRUITING

Trial details

NCT number: NCT06807281
Sponsor: Pfizer
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Atopic Dermatitis

Start date: 2025-12-02
Primary completion: 2032-02-22
Enrollment: 500

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.